Success Stories: EB-1A Approved for Assistant Professor in New York in the Field of Nanotechnology & Biomedical Engineering
On March 12, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for an Assistant Professor in the Field of Nanotechnology & Biomedical Engineering (Approval Notice)
Position at the Time of Case Filing: Assistant Professor
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: March 12th, 2015
Processing Time: 29 Days (10 Days After Requesting Premium Processing)
Our client in this case was an Assistant Professor from China who had primarily worked on engineering several pertinent materials and technologies related to medical diagnosis and therapy. His work had resulted in 26 peer-reviewed scientific articles, 23 presentations at national and international conferences, and 2 patents; at the time that his case was filed, his publications had been cited at least 542 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 14 manuscripts for 12 distinctive, internationally-circulated journals. An independent recommender remarked upon his superior expertise: “[Client] and his team developed a microfluidic microfiltration platform that efficiently isolates and purifies different subpopulations of immune cells directly from blood samples, which creates a functional immunophenotype for patients. This accomplishment is the first of its kind, and a vital advancement in medical technology used for diagnosing and treating such diseases as HIV, malaria, and sepsis. It will also allow physicians to effectively monitor immune responses in cancer patients undergoing treatment.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Nanotechnology and Biomedical Engineering, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in twenty-nine days.